Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$1.87 -0.07 (-3.61%)
As of: Oct 21, 2026 · 3:50 PM EDT

Xtl Biopharmaceuticals (XTLB) Change in Other Operating Liabilities (2009 - 2014)

Updated

Analysis

Xtl Biopharmaceuticals (XTLB) Change in Other Operating Liabilities (2009 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -972.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -112.00 Mn
10 Xtl Biopharmaceuticals 16.76 Mn 13.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -4,000.00
Jun 30, 2014 17,000.00
Mar 31, 2014 -1,000.00
Dec 31, 2009 447,000.00
Mar 31, 2009 -447,000.00
API Access

Xtl Biopharmaceuticals Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=XTLB&period=max&api_key=YOUR_API_KEY